Table 2.

Baseline characteristics by miR-31-3p expression subgroups

Low (n = 229)High (n = 111)
Gender
 Female65 (29%)38 (34%)
 Male163 (71%)73 (66%)
Age, y
 ≤65121 (53%)57 (51%)
 >65108 (47%)54 (49%)
 Median (y)6464
BRAF statusa
 WT218 (95%)80 (72%)
 Mutant11 (5%)31 (28%)
Number of metastatic sites
 1103 (45%)47 (42%)
 ≥2125 (55%)64 (58%)
 Median22
ECOG score
 0123 (54%)57 (51%)
 1104 (45%)52 (47%)
 22 (1%)2 (2%)
Tumor sidednessa
 Left + rectum191 (88%)69 (63%)
 Right26 (12%)41 (37%)
  • NOTE: Percentages calculated on patients without missing data (13 missing for sidedness, 1 missing for gender, 1 for number of metastatic sites).

  • aP < 0.05.